Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates – Intellia Therapeutics

  1. Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates  Intellia Therapeutics
  2. Intellia Gears Up to Report Q3 Earnings: What’s in the Cards?  Zacks Investment Research
  3. NTLA FY2027 EPS Reduced by Brookline Capital Management  MarketBeat
  4. Intellia (NASDAQ: NTLA) completes HAELO Phase 3 enrollment; topline mid-2026  Stock Titan
  5. Intellia Therapeutics (NTLA) Expected to Announce Quarterly Earnings on Thursday  MarketBeat

Continue Reading